Your search returned 7 results.

Results
	1.	Finding the perfect spot for fluorine: improving potency up to 40-fold during a rational fluorine scan of a Bruton's Tyrosine Kinase (BTK) inhibitor scaffold. [electronic resource] by Lou, Yan Sweeney, Zachary K Kuglstatter, Andreas Davis, Dana Goldstein, David M Han, Xiaochun Hong, Junbae Kocer, Buelent Kondru, Rama K Litman, Renee McIntosh, Joel Sarma, Keshab Suh, Judy Taygerly, Joshua Owens, Timothy D Producer: 20150921 In: Bioorganic & medicinal chemistry letters vol. 25 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	2.	Prospective discovery of small molecule enhancers of an E3 ligase-substrate interaction. [electronic resource] by Simonetta, Kyle R Taygerly, Joshua Boyle, Kathleen Basham, Stephen E Padovani, Chris Lou, Yan Cummins, Thomas J Yung, Stephanie L von Soly, Szerenke Kiss Kayser, Frank Kuriyan, John Rape, Michael Cardozo, Mario Gallop, Mark A Bence, Neil F Barsanti, Paul A Saha, Anjanabha Producer: 20190503 In: Nature communications vol. 10 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	3.	Discovery of a novel series of potent non-nucleoside inhibitors of hepatitis C virus NS5B. [electronic resource] by Schoenfeld, Ryan C Bourdet, David L Brameld, Ken A Chin, Elbert de Vicente, Javier Fung, Amy Harris, Seth F Lee, Eun K Le Pogam, Sophie Leveque, Vincent Li, Jim Lui, Alfred S-T Najera, Isabel Rajyaguru, Sonal Sangi, Michael Steiner, Sandra Talamas, Francisco X Taygerly, Joshua P Zhao, Junping Producer: 20140310 In: Journal of medicinal chemistry vol. 56 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	4.	Structure-based drug design of RN486, a potent and selective Bruton's tyrosine kinase (BTK) inhibitor, for the treatment of rheumatoid arthritis. [electronic resource] by Lou, Yan Han, Xiaochun Kuglstatter, Andreas Kondru, Rama K Sweeney, Zachary K Soth, Michael McIntosh, Joel Litman, Renee Suh, Judy Kocer, Buelent Davis, Dana Park, Jaehyeon Frauchiger, Sandra Dewdney, Nolan Zecic, Hasim Taygerly, Joshua P Sarma, Keshab Hong, Junbae Hill, Ronald J Gabriel, Tobias Goldstein, David M Owens, Timothy D Producer: 20150427 In: Journal of medicinal chemistry vol. 58 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	5.	Discovery of INT131: a selective PPARγ modulator that enhances insulin sensitivity. [electronic resource] by Taygerly, Joshua P McGee, Lawrence R Rubenstein, Steven M Houze, Jonathan B Cushing, Timothy D Li, Yang Motani, Alykhan Chen, Jin-Long Frankmoelle, Walter Ye, Guosen Learned, Marc R Jaen, Juan Miao, Shichang Timmermans, Pieter B Thoolen, Martin Kearney, Patrick Flygare, John Beckmann, Holger Weiszmann, Jennifer Lindstrom, Michelle Walker, Nigel Liu, Jinsong Biermann, Donna Wang, Zhulun Hagiwara, Atsushi Iida, Tetsuya Aramaki, Hisateru Kitao, Yuki Shinkai, Hisashi Furukawa, Noboru Nishiu, Jun Nakamura, Motonao Producer: 20130816 In: Bioorganic & medicinal chemistry vol. 21 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	6.	Discovery of N-[4-[6-tert-butyl-5-methoxy-8-(6-methoxy-2-oxo-1H-pyridin-3-yl)-3-quinolyl]phenyl]methanesulfonamide (RG7109), a potent inhibitor of the hepatitis C virus NS5B polymerase. [electronic resource] by Talamas, Francisco X Abbot, Sarah C Anand, Shalini Brameld, Ken A Carter, David S Chen, Jun Davis, Dana de Vicente, Javier Fung, Amy D Gong, Leyi Harris, Seth F Inbar, Petra Labadie, Sharada S Lee, Eun K Lemoine, Remy Le Pogam, Sophie Leveque, Vincent Li, Jim McIntosh, Joel Nájera, Isabel Park, Jaehyeon Railkar, Aruna Rajyaguru, Sonal Sangi, Michael Schoenfeld, Ryan C Staben, Leanna R Tan, Yunchou Taygerly, Joshua P Villaseñor, Armando G Weller, Paul E Producer: 20140515 In: Journal of medicinal chemistry vol. 57 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	7.	AMG 176, a Selective MCL1 Inhibitor, Is Effective in Hematologic Cancer Models Alone and in Combination with Established Therapies. [electronic resource] by Caenepeel, Sean Brown, Sean P Belmontes, Brian Moody, Gordon Keegan, Kathleen S Chui, Danny Whittington, Douglas A Huang, Xin Poppe, Leszek Cheng, Alan C Cardozo, Mario Houze, Jonathan Li, Yunxiao Lucas, Brian Paras, Nick A Wang, Xianghong Taygerly, Joshua P Vimolratana, Marc Zancanella, Manuel Zhu, Liusheng Cajulis, Elaina Osgood, Tao Sun, Jan Damon, Leah Egan, Regina K Greninger, Patricia McClanaghan, Joseph D Gong, Jianan Moujalled, Donia Pomilio, Giovanna Beltran, Pedro Benes, Cyril H Roberts, Andrew W Huang, David C Wei, Andrew Canon, Jude Coxon, Angela Hughes, Paul E Producer: 20191223 In: Cancer discovery vol. 8 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)